Delcath Systems Stock

Delcath Systems Diluted EPS

The Diluted Earnings per Share of Delcath Systems (DCTH) as of Aug 16, 2026 is 0.07 USD. In the previous year, Diluted Earnings per Share was -0.93 USD — a change of -107.31% (higher).

Diluted EPS

0.07USD

YoY

-107.31%

Last updated:

Diluted Earnings per Share of Delcath Systems is 2026 0.07 USD. Diluted Earnings per Share of Delcath Systems was 2025 -0.93 USD. It decreases by -107.31% higher compared to the previous year.
Access this data via the Eulerpool API

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delcath Systems stock

Diluted Earnings per Share of Delcath Systems is 0.07 USD in 2026.

Diluted Earnings per Share of Delcath Systems changed from -0.93 USD to 0.07 USD, representing a -107.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Delcath Systems since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

Income Statement — Delcath Systems

All Key Metrics — Delcath Systems